Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays an error screen instead of the study record. This prevents access to the study details and related information on NCT03815058.SummaryDifference17%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated to v3.6.4, indicating a backend update to the ClinicalTrials.gov page. This update appears to be a software version change rather than a modification to study details.SummaryDifference0.0%

- Check47 days agoChange DetectedA new revision tag v3.6.3 was added and the previous v3.6.2 tag was removed from the page, updating the revision history.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page's revision label updated from v3.6.0 to v3.6.2, indicating a minor behind-the-scenes update to the page version.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page adds a line indicating recruitment is closed ('No longer looking for participants') and introduces new or reorganized sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', plus a Revision: v3.6.0 notice.SummaryDifference0.3%

- Check76 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a newer version of the page.SummaryDifference0.0%

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.